Lainate, Italy

Emanuela Fumagalli

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Emanuela Fumagalli: A Trailblazer in Pharmaceutical Innovations

Introduction

Emanuela Fumagalli, an accomplished inventor based in Lainate, Italy, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 4 patents, her work primarily focuses on the innovative application of Rifaximin, a medication used to treat various gastrointestinal conditions.

Latest Patents

Fumagalli's latest patents detail a groundbreaking polymorphic mixture of Rifaximin, specifically its α/β forms in a relative ratio of 85/15 ± 3. This polymorphic mixture is poised to enhance treatment options for conditions such as traveler's diarrhea and hepatic encephalopathy. Moreover, her patents include formulations that utilize this mixture as an active ingredient in solid pharmaceutical compositions, particularly in film-coated tablets. This innovative approach aims to improve the medicinal efficacy of Rifaximin while ensuring efficient formulation processes.

Career Highlights

Emanuela Fumagalli has had a distinguished career, working with leading companies in the pharmaceutical sector. Notably, she has contributed her expertise at Amri Italy S.r.l. and Curia IP Holdings, LLC. Her work has significantly shaped the landscape of pharmaceutical innovations surrounding Rifaximin and its applications.

Collaborations

Throughout her career, Fumagalli has collaborated with notable professionals in her field, including Paride Grisenti and Maria Argese. These partnerships have enriched her research and development efforts, further driving innovation in pharmaceutical formulations and practices.

Conclusion

Emanuela Fumagalli's contributions to pharmaceutical science exemplify the impact of innovative thinking on healthcare solutions. Her advancements in the formulation of Rifaximin not only highlight her prowess as an inventor but also underscore the importance of collaboration in achieving breakthroughs in medicine. As she continues her work, the pharmaceutical industry eagerly anticipates her future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…